Blockade of prostaglandin E2 receptor 4 ameliorates nephrotoxic serum nephritis
- 1 December 2018
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 315 (6) , F1869-F1880
Abstract
Prostaglandin E2 (PGE2) signaling is known to modulate inflammation and vascular resistance. Receptors of PGE2 [E-type prostanoid receptors (EP)] might be an attractive pharmacological target in immune-mediated diseases such as glomerulonephritis. We hypothesized that selective EP4 antagonism improves nephrotoxic serum nephritis (NTS) by its anti-inflammatory properties. Mice were subjected to NTS and treated with the EP4 antagonist ONO AE3-208 (10 mg·kg body wt−1·day−1] or vehicle starting from disease initiation. In one set of experiments, treatment was started 4 days after NTS induction. Tubular epithelial cells were evaluated in vitro under starving conditions. EP4 antagonist treatment significantly improved the NTS phenotype without affecting blood pressure levels. Remarkably, the improved NTS phenotype was also observed when treatment was started 4 days after NTS induction. EP4 antagonism decreased tubular chemokine (C-X-C motif) ligand ( Cxcl) 1 and Cxcl-5 expression and thereby subsequently reduced interstitial neutrophil infiltration into the kidney. In vitro, tubular epithelial cells increasingly expressed Cxcl-5 mRNA and Cxcl-5 protein when treated with PGE2 or an EP4 agonist under starving conditions, which was blunted by EP4 antagonist treatment. Together, EP4 antagonism improves the NTS phenotype, probably by decreasing mainly Cxcl-5 production in tubular cells, thereby reducing renal neutrophil infiltration.Keywords
Funding Information
- Austrian Science Fund (FWF) (W1241, P-27537, P-22521)
- Oesterreichische Nationalbank (Austrian National Bank) (14263, 17212)
This publication has 38 references indexed in Scilit:
- Chronic administration of EP4-selective agonist exacerbates albuminuria and fibrosis of the kidney in streptozotocin-induced diabetic mice through IL-6Laboratory Investigation, 2013
- Lipocalin-2 Expressed in Innate Immune Cells Is an Endogenous Inhibitor of Inflammation in Murine Nephrotoxic Serum NephritisPLOS ONE, 2013
- E-type prostanoid receptor 4 (EP4) in disease and therapyPharmacology & Therapeutics, 2013
- Recombinant Expression and Characterization of Human and Murine ACE2: Species‐Specific Activation of the Alternative Renin‐Angiotensin‐SystemInternational Journal of Hypertension, 2012
- Dual roles of PGE 2 -EP4 signaling in mouse experimental autoimmune encephalomyelitisProceedings of the National Academy of Sciences, 2010
- CCR6 Recruits Regulatory T Cells and Th17 Cells to the Kidney in GlomerulonephritisJournal of the American Society of Nephrology, 2010
- CCR7 Deficiency Exacerbates Injury in Acute Nephritis Due to Aberrant Localization of Regulatory T CellsJournal of the American Society of Nephrology, 2010
- Th1 and Th17 Cells Induce Proliferative GlomerulonephritisJournal of the American Society of Nephrology, 2009
- CCR7-specific migration to CCL19 and CCL21 is induced by PGE2 stimulation in human monocytes: Involvement of EP2/EP4 receptors activationMolecular Immunology, 2009
- Prostaglandin E2promotes cell survival of glomerular epithelial cells via the EP4 receptorAmerican Journal of Physiology-Renal Physiology, 2006